Pharmacy Times provides pharmacy practice news and expert insights, focusing on issues relevant to pharmacy professionals.

Pharmacy Times

Media Production

MJH Life Sciences®

Pharmacy Times | 82,889 followers on LinkedIn. Everything pharmacy, every day. | Pharmacy Times is a clinically-based, monthly journal providing practical information pharmacists can use in their everyday practice. Each issue contains articles and features covering medication errors, drug interactions, patient education, pharmacy technology, disease state management, patient counseling, product news, pharmacy law, and specialty pharmacy. Pharmacy Times Continuing Education (PTCE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Principal at Genesis Pharma Consultants

Dan Steiber

Executive Vice-President and Chief Impact Officer

Nimesh Jhaveri

The Digital Apothecary (Professor, Clinician, Public Speaker, and Advisor)

Timothy Aungst, PharmD.

Proofreader at MJH Associates, Inc

Maggie Shaw

Your pharmacy news, streamlined. We're bringing curated content straight to your feed with our new newsletter. 📰 What matters most to you? #PharmacyTimesPoll #Pharmacy #LinkedinNewsletter

Pharmacists can help patients to understand individual joint health needs and encourage them to follow healthy lifestyle habits as part of their proactive joint health regimen. #pharmacist Learn more: https://lnkd.in/eAk-ZVpF

The FDA proposed the removal of oral phenylephrine (Sudafed PE; Johnson & Johnson) as an active ingredient in OTC drug products for the temporary relief of nasal congestion. The proposal is based on extensive review by the agency, which found that oral phenylephrine is not effective for this use. Learn more: https://bit.ly/3CkMItO

Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these racial disparities in opioid prescriptions. Learn more: https://bit.ly/4fBljlQ

Researchers announced positive findings from the phase 2b/3 MK-1654-004 clinical trial that assessed clesrovimab (MK-1654; Merck), an investigational monoclonal prophylactic monoclonal antibody designed to protect infants from respiratory syncytial virus (RSV) infection in their first RSV season. Learn more: https://bit.ly/3NUIFXR

The FDA approved minocycline hydrochloride extended-release capsules (DFD-29, Emrosi; Journey Medical) for the treatment of adults with inflammatory lesions caused by rosacea. Learn more: https://bit.ly/3YznMpY

In the Institute for Safe Medication Practices (ISMP) National Vaccine Errors Reporting Program (VERP), investigators reported that the majority of reported errors (82.3%) reached the patient, with the most reported errors including administering the wrong vaccine (25.2%) and administering an expired vaccine (19.8%). Learn more: https://bit.ly/3UAtvKM

At the FLASCO Fall Session, American Society of Clinical Oncology (ASCO) VP of Care Delivery Stephen Grubbs, MD, FASCO, highlighted the increasing impact of pharmacists within ASCO, from developing safety standards to leading quality improvement and certification initiatives. With pharmacists, such as Michael Reff of NCODA and Alexandre Chan, PharmD, MPH, FCCP, FISOPP, BCPS, BCOP, APh of UCI School of Pharmacy & Pharmaceutical Sciences , significantly contributing to ASCO/NCODA and ASCO/ONS standards, ASCO aims to expand opportunities and address barriers—potentially such as CE credits for pharmacists at its annual meeting—to further support pharmacists crucial role in oncology care. #OncologyPharmacy #PharmacistImpact #ASCO #QualityCare https://lnkd.in/eCyZ39jW

Although the number of active shortages decreased to 277 in the second quarter of 2024 from an all-time high of 323 in the second quarter of 2023, 50% of the active shortages in the United States persisted for 2 or more years. Learn more: https://bit.ly/3AcPT6l

No tricks, just treatments! We hope you find the perfect prescription for a safe and spooky Halloween. 👻🎃 #HappyHalloween #PharmacyCare #PharmacyTimes

PHAR

COM:PHARMACYTIMES

Pharmacy Times